The most prominent oncogenic driver in HNSCC is the epidermal growth factor receptor (EGFR), a transmembrane receptor tyrosine kinase that is expressed or over-expressed in more than 90% of all HNSCCs (4). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.